22% of men survive pancreatic cancer for at least one year, and this is predicted to fall to 4% surviving for five years or more, as shown by
Pancreatic Cancer (C25), Age-Standardised One-, Five- and Ten-Year Net Survival, Adults (Aged 15-99), England and Wales, 2010-2011
|1-Year Survival (%)||5-Year Survival (%)||10-Year Survival (%)|
95% LCL and 95% UCL are the 95% lower and upper
Five- and ten-year survival is predicted using an excess hazard statistical model
Pancreatic cancer survival gradually continues to fall beyond five years after diagnosis. Just 1% of men and women are predicted to survive their disease for ten years or more, as shown by age-standardised net survival for patients diagnosed with pancreatic cancer during 2010-2011 in England and Wales. Out of 20 common cancers in England and Wales, ten-year survival for pancreatic cancer ranks lowest overall.
Pancreatic Cancer (C25), Net Survival up to Ten Years after Diagnosis, Adults (Aged 15-99), England and Wales, 2010-2011
Survival for pancreatic cancer is reported in Scotland and Northern Ireland,[2,3] though it is difficult to make survival comparisons between countries due to different methodologies and criteria for including patients in analyses. An analysis of patients diagnosed with pancreatic cancer during 1995-2009 suggests one-year relative survival is similar in England, Wales and Scotland.
- Data were provided by London School of Hygiene and Tropical Medicine on request, 2014.
- ISD Scotland. Trends in Cancer Survival 1983-2007.
- Northern Ireland Cancer Registry. Incidence & Survival 1993-2012.
- National Cancer Intelligence Network. NCIN Data Briefing: One-year relative survival rates for pancreatic cancer in Great Britain, 1995-2009. London: NCIN; 2014.